Cardiogenic Shock Clinical Trials

65 recruiting

Cardiogenic Shock Trials at a Glance

68 actively recruiting trials for cardiogenic shock are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 19 trials, with the heaviest enrollment activity in Strasbourg, Milan, and Falls Church. Lead sponsors running cardiogenic shock studies include Assistance Publique - Hôpitaux de Paris, Tufts Medical Center, and Centre Hospitalier Universitaire, Amiens.

Browse cardiogenic shock trials by phase

Treatments under study

About Cardiogenic Shock Clinical Trials

Looking for clinical trials for Cardiogenic Shock? There are currently 65 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiogenic Shock trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiogenic Shock clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 68 trials

Recruiting
Phase 2

Physiology of Unloading VA ECMO Trial

Cardiogenic Shock
University of Utah104 enrolled1 locationNCT06336655
Recruiting
Not Applicable

Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock

Cardiogenic ShockAortic Stenosis
Rigshospitalet, Denmark30 enrolled1 locationNCT06638268
Recruiting

Altshock-2 REGISTRY

Cardiogenic Shock
Niguarda Hospital3,000 enrolled1 locationNCT04295252
Recruiting
Not Applicable

Early Preventive Left Ventricle Unloading After VA-ECMO for Refractory Cardiogenic Shock

Cardiogenic Shock Acute
Assistance Publique - Hôpitaux de Paris298 enrolled12 locationsNCT07027202
Recruiting
Phase 4

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Heart FailureCardiogenic ShockKetone Body Metabolism+2 more
Institute for Clinical and Experimental Medicine12 enrolled1 locationNCT07527156
Recruiting
Not Applicable

Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

Cardiogenic Shock
CMC Ambroise Paré406 enrolled11 locationsNCT07345559
Recruiting

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

Cardiogenic ShockAcute Heart Failure (AHF)
University Heart Center Freiburg - Bad Krozingen600 enrolled4 locationsNCT07515508
Recruiting

Characterisation of phenotYpes in aCute Heart faiLure patiEnts

Cardiogenic ShockAcute Heart FailureDecompensated Heart Failure
Universitätsklinikum Hamburg-Eppendorf1,000 enrolled1 locationNCT07508891
Recruiting
Phase 4

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

Myocardial InfarctionCardiogenic Shock
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)776 enrolled1 locationNCT05168462
Recruiting

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

AMI Cardiogenic Shock
Abiomed Inc.350 enrolled10 locationsNCT06964685
Recruiting

Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock

Cardiogenic ShockAcute Myocardial Infarction
STAVROS G DRAKOS500 enrolled3 locationsNCT05185492
Recruiting
Not Applicable

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Heart FailureCardiogenic ShockAmbulatory Hemodynamic Monitoring
Inova Health Care Services40 enrolled1 locationNCT04419480
Recruiting

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Cardiogenic Shock
Inova Health Care Services3,000 enrolled1 locationNCT03378739
Recruiting
Not Applicable

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Heart FailureCardiogenic ShockAcute Myocardial Infarction (AMI)
Magenta Medical Ltd.10 enrolled5 locationsNCT07293923
Recruiting

Intra-aortic Balloon Counterpulsation (IABC) Compliance

Cardiogenic ShockIABC ProcedureIntraaortic Balloon Counterpulsation (IABC)
Thomas Jefferson University20 enrolled1 locationNCT07402018
Recruiting
Not Applicable

On Scene ECPR in Ostrava

Cardiogenic ShockCardiac Arrest (CA)
University Hospital Ostrava90 enrolled2 locationsNCT07374289
Recruiting
Phase 2

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Heart FailureCardiomyopathiesCardiogenic Shock+1 more
Stanford University50 enrolled5 locationsNCT06080074
Recruiting

Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock

Septic ShockMyocardial Infarction (MI)Mechanical Circulatory Support+3 more
Centre Hospitalier Universitaire, Amiens2,500 enrolled1 locationNCT07354568
Recruiting
Phase 4

Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator

Acute Kidney InjuryCardiogenic Shock
Samsung Medical Center408 enrolled2 locationsNCT06696235
Recruiting
Not Applicable

A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support

Cardiogenic Shock
Erasmus Medical Center430 enrolled14 locationsNCT05913622